221 related articles for article (PubMed ID: 20674154)
1. NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylation.
Chattopadhyay M; Goswami S; Rodes DB; Kodela R; Velazquez CA; Boring D; Crowell JA; Kashfi K
Cancer Lett; 2010 Dec; 298(2):204-11. PubMed ID: 20674154
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention.
Williams JL; Nath N; Chen J; Hundley TR; Gao J; Kopelovich L; Kashfi K; Rigas B
Cancer Res; 2003 Nov; 63(22):7613-8. PubMed ID: 14633677
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation.
Takada Y; Bhardwaj A; Potdar P; Aggarwal BB
Oncogene; 2004 Dec; 23(57):9247-58. PubMed ID: 15489888
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
[TBL] [Abstract][Full Text] [Related]
5. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.
Chattopadhyay M; Kodela R; Olson KR; Kashfi K
Biochem Biophys Res Commun; 2012 Mar; 419(3):523-8. PubMed ID: 22366248
[TBL] [Abstract][Full Text] [Related]
6. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
Konturek PC; Kania J; Burnat G; Hahn EG
J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
[TBL] [Abstract][Full Text] [Related]
7. Abnormal nuclear factor (NF)-kappaB signal pathway and aspirin inhibits tumor necrosis factor alpha-induced NF-kappaB activation in keloid fibroblasts.
Zhu G; Cai J; Zhang J; Zhao Y; Xu B
Dermatol Surg; 2007 Jun; 33(6):697-708. PubMed ID: 17550447
[TBL] [Abstract][Full Text] [Related]
8. Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling.
Redlak MJ; Power JJ; Miller TA
J Surg Res; 2008 Mar; 145(1):66-73. PubMed ID: 17644113
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
[TBL] [Abstract][Full Text] [Related]
10. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
Muscará MN; McKnight W; Asfaha S; Wallace JL
Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha.
Fiorucci S; Santucci L; Federici B; Antonelli E; Distrutti E; Morelli O; Renzo GD; Coata G; Cirino G; Soldato PD; Morelli A
Aliment Pharmacol Ther; 1999 Mar; 13(3):421-35. PubMed ID: 10102977
[TBL] [Abstract][Full Text] [Related]
12. Dicaffeoylquinic acids in Yerba mate (Ilex paraguariensis St. Hilaire) inhibit NF-κB nucleus translocation in macrophages and induce apoptosis by activating caspases-8 and -3 in human colon cancer cells.
Puangpraphant S; Berhow MA; Vermillion K; Potts G; Gonzalez de Mejia E
Mol Nutr Food Res; 2011 Oct; 55(10):1509-22. PubMed ID: 21656672
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect.
Chattopadhyay M; Kodela R; Nath N; Dastagirzada YM; Velázquez-Martínez CA; Boring D; Kashfi K
Biochem Pharmacol; 2012 Mar; 83(6):715-22. PubMed ID: 22222427
[TBL] [Abstract][Full Text] [Related]
14. NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives.
Zacharowski P; Breese E; Wood E; Del Soldato P; Warner T; Mitchell J
Eur J Pharmacol; 2005 Jan; 508(1-3):7-13. PubMed ID: 15680249
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling.
Kodela R; Nath N; Chattopadhyay M; Nesbitt DE; Velázquez-Martínez CA; Kashfi K
Drug Des Devel Ther; 2015; 9():4873-82. PubMed ID: 26346117
[TBL] [Abstract][Full Text] [Related]
16. Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo.
Kashfi K; Borgo S; Williams JL; Chen J; Gao J; Glekas A; Benedini F; Del Soldato P; Rigas B
J Pharmacol Exp Ther; 2005 Mar; 312(3):978-88. PubMed ID: 15528453
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro.
Dial EJ; Doyen JR; Lichtenberger LM
Cancer Chemother Pharmacol; 2006 Feb; 57(3):295-300. PubMed ID: 16032431
[TBL] [Abstract][Full Text] [Related]
18. A molecular mechanism for the anti-inflammatory effect of taurine-conjugated 5-aminosalicylic acid in inflamed colon.
Kim H; Jeon H; Kong H; Yang Y; Choi B; Kim YM; Neckers L; Jung Y
Mol Pharmacol; 2006 Apr; 69(4):1405-12. PubMed ID: 16407467
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
[TBL] [Abstract][Full Text] [Related]
20. Molecular targets of nitric-oxide-donating aspirin in cancer.
Kashfi K; Rigas B
Biochem Soc Trans; 2005 Aug; 33(Pt 4):701-4. PubMed ID: 16042578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]